Skip to main content
×
×
Home

Q fever: an under-reported reportable communicable disease

  • Harvey W. Kaufman (a1), Zhen Chen (a1), Jeff Radcliff (a1), Hollis J. Batterman (a1) and John Leake (a1)...
Abstract

The objective of this study was to provide real-world clinical laboratory-based data to supplement Centers for Disease Control and Prevention (CDC) reporting of Q fever. We analysed titre results of specimens submitted to a large US clinical laboratory for Coxiella burnetii IgG antibody testing from 2010 through 2016. Presumptive Q fever was defined as acute (phase II IgG titre ⩾1:128, phase I titre <1:1024) or chronic (phase I IgG titre ⩾1:1024), based on the results from a single serum specimen. During 2010–2016, an average of 328 presumptive acute Q fever cases were identified at Quest each year, nearly three times the annual average reported to the CDC (122). During the same period, the number of chronic cases identified annually at Quest Diagnostics (34) was similar to that reported to the CDC (29). These findings suggest that CDC data may underestimate the incidence of acute Q fever.

Copyright
Corresponding author
Author for correspondence: Harvey W. Kaufman, E-mail: Harvey.W.Kaufman@QuestDiagnostics.com
References
Hide All
1.Chorba, TL et al. (1990) Mandatory reporting of infectious diseases by clinicians. Morbidity and Mortality Weekly Report Recommendations and Reports 39, 111, 16–17.
2.Anderson, A et al. (2013) Diagnosis and management of Q fever – United States, 2013: recommendations from CDC and the Q Fever Working Group. Morbidity and Mortality Weekly Report Recommendations and Reports 62, 130.
3.Q Fever, Statistics and epidemiology. Available at https://www.cdc.gov/qfever/stats/index.html.
4.Hoek, W et al. (2012) Relation between Q fever notifications and Coxiella burnetii infections during the 2009 outbreak in The Netherlands. Euro Surveillance 17, 20058.
5.Q fever IFA IgG [package insert]. Focus Diagnostics. California: Cypress. Revision J, 12 August 2016. Available at https://www.focusdx.com/pdfs/pi/US/IF0200G.pdf (Accessed 15 November 2017).
6.Fenollar, F et al. (2001) Risk factors and prevention of Q fever endocarditis. Clinical Infectious Diseases 33, 312316.
7.Sickbert-Bennett, EE et al. (2011) Completeness of communicable disease reporting, North Carolina, USA, 1995–1997 and 2000–2006. Emerging Infectious Diseases 17, 2329.
8.Dahlgren, FS, Haberling, DL and McQuiston, JH (2015) Q fever is underestimated in the United States: a comparison of fatal Q fever cases from two national reporting systems. American Journal of Tropical Medicine and Hygiene 92, 244246.
9.Adams, DA et al. (2012) Summary of notifiable diseases – United States, 2010. Morbidity and Mortality Weekly Report 59, 1111.
10.Adams, DA et al. (2013) Summary of notifiable diseases – United States, 2011. Morbidity and Mortality Weekly Report 60, 1117.
11.Adams, DA et al. (2014) Summary of notifiable diseases – United States, 2012. Morbidity and Mortality Weekly Report 61, 1121.
12.Adams, DA et al. (2015) Summary of notifiable infectious diseases and conditions – United States, 2013. Morbidity and Mortality Weekly Report 62, 1119.
13.Adams, DA et al. (2016) Summary of notifiable infectious diseases and conditions – United States, 2014. Morbidity and Mortality Weekly Report 63, 1152.
14.Adams, DA et al. (2017) Summary of notifiable infectious diseases and conditions – United States, 2015. Morbidity and Mortality Weekly Report 64, 1143.
15.CDC (2017) National Notifiable Diseases Surveillance System, 2016 Annual Tables of Infectious Disease Data. Atlanta, GA: CDC Division of Health Informatics and Surveillance. Available at https://www.cdc.gov/nndss/infectious-tables.html.
16.Marier, R (1977) The reporting of communicable diseases. American Journal of Epidemiology 105, 587590.
17.Thacker, SB and Berkelman, RL (1988) Public health surveillance in the United States. Epidemiology Review 10, 164190.
18.Doyle, TJ, Glynn, MK and Groseclose, SL (2002) Completeness of notifiable infectious disease reporting in the United States: an analytical literature review. Practice Epidemiology 155, 866874.
19.Nguyen, TQ et al. (2007) Benefits and barriers to electronic laboratory results reporting for notifiable diseases: the New York City Department of Health and Mental Hygiene experience. American Journal of Public Health 97, S142S145.
20.Gluskin, RT, Mavinkurve, M and Varma, JK (2014) Government leadership in addressing public health priorities: strides and delays in electronic laboratory reporting in the United States. American Journal of Public Health 104, e16e21.
21.Shapiro, JS et al. (2011) Using health information exchange to improve public health. American Journal of Public Health 101, 616623.
22.Weiss, BP, Strassburg, MA and Fannin, SL (1988) Improving disease reporting in Los Angeles County: trial and results. Public Health Report 103, 415421.
23.Konowitz, PM, Petrossian, GA and Rose, DN (1984) The underreporting of disease and physicians’ knowledge of reporting requirements. Public Health Report 99, 3135.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed